By tracing cancers back to their cells of origin, Columbia researchers are learning why some cancers become aggressive.
Dr. McKiernan is a nationally recognized leader in surgical therapies for bladder, kidney, prostate, and testicular cancers.
Two genes together drive the most lethal forms of prostate cancer; could lead to diagnostic test and new treatments.
The American Medical Association has honored P&S student Gregory Joice for his research.
The discovery of progenitor cells in the bladder could lead to new ways to treat chronic bladder pain.
A new genetic test may help determine which men with early prostate cancer can avoid surgery or other invasive treatment.